Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

A legfontosabb adatok

Ki végzi
Cochlear
Hol
Cleveland, Kansas City és Worcester (Egyesült Államok)Mind a 4 helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
10 fő vett részt
Kezdés
2021. dec. 16.
Befejezés
2025. jún. 16.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • CI632 Slim Modiolar Electrode
A regiszteradat frissítve
2026. augusztus 17.

Ki vehet részt

Életkor
18 év – 69 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • 18 years-of-age or older at the time of surgery
  • Low-frequency threshold at 500 Hz ≤ 50 dB HL and high-frequency pure-tone average (PTA), 2000-8000 Hz ≥ 65 dB HL in the ear to be implanted
  • Pure-tone average (PTA) (0.5k, 1k, 2k Hz) > 30 dB HL in the contralateral ear
  • CNC word recognition scores (mean of two lists) ≤ 60% in the ear to be implanted and ≤ 80% in the contralateral ear
  • English spoken as a primary language
  • Willing and able to provide written informed consent

Ki nem vehet részt

  • Individuals greater than or equal to 70 years at the time of surgery
  • Onset of sensorineural hearing loss, for the purpose of this study, prior to 5 years-of-age
  • Currently participating, or has participated in the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device
  • Active middle-ear infection
  • Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator
  • Duration of severe to profound sensorineural hearing loss > 20 years per self-report
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array
  • Conductive overlay of 15 dB or greater at two or more frequencies, in the range of 250 through 1000 Hz in the ear to be implanted
  • Hearing loss of neural or central origin
  • Diagnosis of Auditory Neuropathy
  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the device and/or procedure, as determined by the Investigator
  • Additional handicaps that would prevent or restrict participation in the audiological evaluations as determined by the Investigator
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate family (spouse, parent, child, or sibling)
  • Cochlear employees or employees of a Contract Research Organization (CRO) or contractors engaged by Cochlear for the purposes of this investigation

Helyszínek itt: Egyesült Államok

  • Cleveland ClinicCleveland, Egyesült Államok
  • University HospitalsCleveland, Egyesült Államok
  • Midwest Ear InstituteKansas City, Egyesült Államok
  • Umass Memorial Medical CenterWorcester, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

A vizsgálat csoportja

  • CI632 Slim Modiolar ElectrodeA vizsgált kezelés

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Pre-market, Open-label Feasibility, Prospective, Single-arm Multicenter Feasibility Investigation of Hearing Performance Using the CI632 in Adults With Low-frequency Residual Hearing.
A regiszteradat frissítve
2026. augusztus 17.